Share
Many primary aldosteronism cases remain undiagnosed and untreated Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as primary aldosteronism in a new Clinical Practice Guideline released today. “Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline” was published online and is being presented at ENDO 2025, the...
Share
Scientific Statement aims to expand our research to advance the understanding of the cause and progression of type 1 diabetes. A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes that should help with the development of new and improved treatment options. ...
Share
As experts dedicated to providing patients with compassionate, evidence-based care every day, we are disappointed in the United States v. Skrmetti decision, which increases the likelihood that other states will limit or eliminate families’ and patients’ ability to access medical care. As doctors, nurse practitioners, and nurses, we believe that every patient is different. Decisions...
Share
Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed to advocating for reducing the burden of prior authorization, when healthcare providers must seek insurance plan approval before...
Share
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate. The legislation will ensure that Medicare and Medicaid beneficiaries have access to effective anti-obesity medications. Medicare coverage of anti-obesity medications is currently prohibited under law. Access to these medications would benefit millions of Americans. More than...
Share
The Endocrine Society has selected Yoshitomo Hoshino, MD, PhD, as the recipient of its 2025 C. Wayne Bardin, MD, International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne...
Share
The Endocrine Society has appointed Manuel Tena-Sempere, MD, PhD, of the University of Cordoba in Spain, as the next editor-in-chief of its flagship basic science journal, Endocrinology, starting January 2026. Manuel Tena-Sempere is a professor of physiology at the University of Cordoba, a research group leader at the biomedical research institute of Cordoba (IMIBIC) and...
Share
The Endocrine Society is extremely disappointed the administration has chosen not to finalize a rule that would have made anti-obesity medications more accessible to millions of Americans with obesity. The administration decided not to implement a proposal that would have allowed Medicare and Medicaid to cover anti-obesity medications for weight loss. Many Medicare and Medicaid...
